Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
about
Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung CancerEpigenetics of lung cancerEpidermal growth factor signaling in transformed cellsNon-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerPotential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis.Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition.Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.Silibinin-Induced Apoptosis and Downregulation of MicroRNA-21 and MicroRNA-155 in MCF-7 Human Breast Cancer CellsResponse of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibininAssociation between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks.HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity StudiesSTAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer.miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.Food-based natural products for cancer management: Is the whole greater than the sum of the parts?Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition.Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis.
P2860
Q26798147-8F3C8192-22E9-4F3B-97CD-49BCBD4501A5Q26996766-C070501E-C877-4118-BF54-1E5E267FEAEAQ28084034-5B1D3B0C-EC42-405C-A031-1DAFC52BD4B0Q33829653-D9A8F22C-3F80-4372-9886-22FF441AC1ACQ34295621-FA59789E-032A-4E52-96AE-667FEC310CFEQ36057439-74B69DBD-6EBF-4652-98B2-27FB22B06E63Q36365503-2B384357-E860-49DA-B5B8-101D8039CCCCQ36414361-E7793A84-F375-4FB6-82CD-749FEDC2300FQ36768990-74FB4B28-9DF7-46A4-BD2D-D78B912AA87DQ37362587-7F29EAEF-DB4A-48C4-8F9E-09AE03B05F5DQ37441567-A8F1E817-0B1D-483B-A76A-D20F3FE1A4F5Q38172182-7B4A6DE6-267D-4355-B690-8D4456D0E8FFQ38639870-9422DC84-8141-4A91-95FF-F400FABFD81FQ38740295-E6348BD1-F284-4D96-9AF1-7CDD3145D645Q38812266-E366A5FF-6498-40D9-A39B-E60E01114B83Q38891659-5F75E617-FF25-431E-BFF3-FB05BAFFD3C2Q39458257-3EAD75F2-EAFA-4258-AF09-7FA280BCA262Q41878464-6CDCB20C-4785-4520-9515-FDC512888167Q50218607-16348AA8-5D9B-466F-AED9-4A4B476601CDQ55070865-61590064-FBA4-41CF-9907-71C14626EBBF
P2860
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Silibinin suppresses EMT-drive ...... low miR-200c signature in vivo
@en
Silibinin suppresses EMT-drive ...... ow miR-200c signature in vivo.
@nl
type
label
Silibinin suppresses EMT-drive ...... low miR-200c signature in vivo
@en
Silibinin suppresses EMT-drive ...... ow miR-200c signature in vivo.
@nl
prefLabel
Silibinin suppresses EMT-drive ...... low miR-200c signature in vivo
@en
Silibinin suppresses EMT-drive ...... ow miR-200c signature in vivo.
@nl
P2093
P2860
P50
P356
P1433
P1476
Silibinin suppresses EMT-drive ...... low miR-200c signature in vivo
@en
P2093
Alejandro Vazquez-Martin
Antonio Segura-Carretero
Bruna Corominas-Faja
Cristina Oliveras-Ferraros
Joana Visa
Rosa Bonavia
Sílvia Cufí
P2860
P2888
P356
10.1038/SREP02459
P407
P50
P577
2013-01-01T00:00:00Z